In vivo MRI Cell Tracking Using Perfluorocarbon Probes And Fluorine-19 Detection

NMR in Biomedicine

Volumn 26, Issue 7, 2013, Pages 860-871

  Ahrens, Eric T ^a   Zhong, Jia ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

19F; Cell therapy; Cell tracking; Inflammation; MRI; Perfluorocarbon; PFC

Indexed keywords

CELL THERAPY; CELL TRACKING; INFLAMMATION; PERFLUOROCARBONS; PFC;

COPYRIGHTS; CYTOLOGY; EXPERIMENTS; FLUORINE; MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROBES; SIGNAL DETECTION;

CELLS;

FLUORINE; FLUOROCARBON; OXYGEN;

ARTICLE; CELL SPECIFICITY; CYTOMETRY; EX VIVO STUDY; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; SENSITIVITY ANALYSIS; SENSOR; SPIN DENSITY;

ANIMALS; CELL TRACKING; CONTRAST MEDIA; FLUORINE; FLUOROCARBONS; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBES;

EID: 84879554594     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2948     Document Type: Article

References (101)

1. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 2007; 58(4): 725-734.
2. Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas, 2010; 39(4): 510-515.
3. Ahrens ET, Young WB, Xu H, Pusateri LK. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques, 2011; 50(4): 229-234.
4. Kadayakkara DK, Ranganathan S, Young WB, Ahrens ET. Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Lab. Invest. 2012; 92(4): 636-645.
5. Riess JG. Oxygen carriers (" blood substitutes " ) - raison d'etre, chemistry, and some physiology. Chem. Rev. 2001; 101(9): 2797-2919.
6. Krafft MP, Riess JG. Perfluorocarbons: life sciences and biomedical uses dedicated to the memory of Professor Guy Ourisson, a true renaissance man. J. Polym. Sci., Part A: Polym. Chem. 2007; 45(7): 1185-1198.
7. Krafft MP, Chittofrati A, Riess JG. Emulsions and microemulsions with a fluorocarbon phase. Curr. Opin. Colloid Interface Sci. 2003; 8(3): 251-258.
8. Krafft MP. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv. Drug Deliv. Rev. 2001; 47(2-3): 209-228.
9. Castro O, Nesbitt AE, Lyles D. Effect of a perfluorocarbon emulsion (fluosol-da) on reticuloendothelial system clearance function. Am. J. Hematol. 1984; 16(1): 15-21.
10. Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science, 1966; 152(3730): 1755-1756.
11. 2 carriers: status in 2005. Curr. Pharm. Des. 2005; 11(31): 4099-4114.
12. Joseph PM, Yuasa Y, Kundel HL, Mukherji B, Sloviter HA. Magnetic resonance imaging of fluorine in rats infused with artificial blood. Invest. Radiol. 1985; 20(5): 504-509.
13. 19F NMR imaging of liver, tumor, and abscess in rats. Preliminary results. Invest. Radiol. 1985; 20(2): 141-145.
14. Holland GN, Bottomley PA, Hinshaw WS. F-19 magnetic-resonance imaging. J. Magn. Reson. 1977; 28(1): 133-136.
15. 19F) MRS and MRI in biomedicine. NMR Biomed.. 2011; 24(2): 114-129.
16. Janjic JM, Ahrens ET. Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009; 1(5): 492-501.
17. 19F magnetic resonance imaging of the reticuloendothelial system. Magn. Reson. Med. 1987; 5(6): 548-554.
18. Giraudeau C, Flament J, Marty B, Boumezbeur F, Meriaux S, Robic C, Port M, Tsapis N, Fattal E, Giacomini E, Lethimonnier F, Le Bihan D, Valette J. A new paradigm for high-sensitivity F-19 magnetic resonance imaging of perfluorooctylbromide. Magn. Reson. Med. 2010; 63(4): 1119-1124.
19. Janjic JM, Srinivas M, Kadayakkara DK, Ahrens ET. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J. Am. Chem. Soc. 2008; 130(9): 2832-2841.
20. Morel PM, Srinivas M, Turner MS, Fuschiotti P, Munschi R, Baha I, Feili-Hariri M, Ahrens ET. Dendritic cells that prevent diabetes in NOD mice express a unique pattern of chemokines that alter the migration of autoreactive T cells. J. Leukocyte Biol. 2011; 90(3): 539-550.
21. 19F MRI. Magn. Reson. Med. 2009; 62(3): 747-753.
22. Gerhardt GE, Lagow RJ. Synthesis of the perfluoropoly(ethylene glycol) ethers by direct fluorination. J. Org. Chem. 1978; 43(23): 4505-4509.
23. Lowe KC. Engineering blood: synthetic substitutes from fluorinated compounds. J. Tissue Eng. 2003; 9(3): 389-399.
24. Waiczies H, Lepore S, Janitzek N, Hagen U, Seifert F, Ittermann B, Purfurst B, Pezzutto A, Paul F, Niendorf T, Waiczies S. Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells. PLoS One 2011; 6(7): e21981.
25. Janjic J, Ahrens ET. Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques. USPTO 2008; 60: 959135.
26. Neubauer AM, Myerson J, Caruthers SD, Hockett FD, Winter PM, Chen JJ, Gaffney PJ, Robertson JD, Lanza GM, Wickline SA. Gadolinium-modulated F-19 signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magn. Reson. Med. 2008; 60(5): 1066-1072.
27. Kok MB, de Vries A, Abdurrachim D, Prompers JJ, Grull H, Nicolay K, Strijkers GJ. Quantitative H-1 MRI, F-19 MRI, and F-19 MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles. Contrast Media Mol. Imaging 2011; 6(1): 19-27.
28. Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. 2004; 108-109: 303-318.
29. Taylor P. Ostwald ripening in emulsions. Adv. Colloid Interface Sci. 1998; 75(2): 107-163.
30. Freire MG, Dias AMA, Coelho MAZ, Coutinho JAP, Marrucho IM. Aging mechanisms of perfluorocarbon emulsions using image analysis. J. Colloid Interface Sci. 2005; 286(1): 224-232.
31. Postel M, Riess JG, Weers JG. Fluorocarbon emulsions - the stability issue. Artif. Cells Blood Substit. Immobil. Biotechnol. 1994; 22(4): 991-1005.
32. Kabalnov AS, Shchukin ED. Ostwald ripening theory. Applications to fluorocarbon emulsion stability. Adv. Colloid Interface Sci. 1992; 38: 69-97.
33. Bible E, Dell'Acqua F, Solanky B, Balducci A, Crapo PM, Badylak SF, Ahrens ET, Modo M. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by F-19- and diffusion-MRI. Biomaterials, 2012; 33(10): 2858-2871.
34. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn. Reson. Med. 2011; 65(4): 1144-1153.
35. Lim YT, Noh YW, Kwon JN, Chung BH. Multifunctional perfluorocarbon nanoemulsions for F-19-based magnetic resonance and near-infrared optical imaging of dendritic cells. Chem. Commun. 2009; 45: 6952-6954.
36. Ahrens ET, Flores R, Xu HY, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005; 23(8): 983-987.
37. O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J. Fluor. Chem. 2012; 137: 27-33.
38. Bulte JWM, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol. 2004; 386: 275-299.
39. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed.. 2004; 17(7): 484-499.
40. 19F magnetic resonance imaging. PLoS One 2011; 6(12): e29040.
41. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn. Reson. Med. 2008; 60(6): 1506-1511.
42. Partlow KC, Chen JJ, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. F-19 magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007; 21(8): 1647-1654.
43. Kadayakkara DK, Janjic JM, Pusateri LK, Young WB, Ahrens ET. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn. Reson. Med. 2010; 64(5): 1252-1259.
44. Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, De Vries IJM, Ahrens ET, Mailliard RB. Functional assessment of human dendritic cells labeled for in vivo F-19 magnetic resonance imaging cell tracking. Cytotherapy 2010; 12(2): 238-250.
45. Helfer BM, Balducci A, Sadeghi Z, O'Hanlon C, Hijaz A, Flask CA, Wesa A. F-19 tracer preserves in vitro and in vivo properties of hematopoietic stem cells. Cell Transplant. 2012; Aug 2 [Epub ahead of print].
46. Genove G, DeMarco U, Xu HY, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 2005; 11(4): 450-454.
47. Iordanova B, Ahrens ET. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage 2012; 59(2): 1004-1012.
48. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005; 7(2): 109-117.
49. Gilad AA, McMahon MT, Walczak P, Winnard PT, Raman V, van Laarhoven HWM, Skoglund CM, Bulte JWM, van Zijl PCM. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 2007; 25(2): 217-219.
50. Dover R, Jayaram Y, Patel K, Chinery R. P53 expression in cultured-cells following radioisotope labeling. J. Cell Sci. 1994; 107: 1181-1184.
51. Srivastava SC, Chervu LR. Radionuclide-labeled red-blood-cells - current status and future prospects. Semin. Nucl. Med. 1984; 14(2): 68-82.
52. Barth RF, Singla O, Gillespi Gy. Use of Tc-99m as a radioisotopic label to study migratory patterns of normal and neoplastic-cells. J. Nucl. Med. 1974; 15(8): 656-661.
53. Gabay C, Kushner I. Mechanisms of disease: acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999; 340(6): 448-454.
54. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005; 5(12): 953-964.
55. Hertlein T, Sturm V, Kircher S, Basse-Lusebrink T, Haddad D, Ohlsen K, Jakob P. Visualization of abscess formation in a murine thigh infection model of Staphylococcus aureus by F-19-magnetic resonance imaging (MRI). PLoS One 2011; 6(3): e18246.
56. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, Schrader J, Flugel U. Early assessment of pulmonary inflammation by (19)F MRI in vivo. Circ. Cardiovasc. Imaging, 2010; 3(2): 202-210.
57. Flögel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008; 118(2): 140-148.
58. Weise G, Basse-Lusebrink TC, Kleinschnitz C, Kampf T, Jakob PM, Stoll G. In vivo imaging of stepwise vessel occlusion in cerebral photothrombosis of mice by F-19 MRI. PLoS One 2011; 6(12): e28143.
59. Balducci A, Helfer BM, Ahrens ET, O'Hanlon CF, Wesa AK. Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (F-19 MRI). J. Inflamm. 2012; 9: 24.
60. Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G. In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp. Neurol. 2011; 229(2): 494-501.
61. 19F MRI in the early stage. Am. J. Transplant. 2011; 11(2): 235-244.
62. Noth U, Morrissey SP, Deichmann R, Jung S, Adolf H, Haase A, Lutz J. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif. Cell Blood Sub. 1997; 25(3): 243-254.
63. 19F magnetic resonance imaging. Invest. Radiol. 1988; 23(5): 361-364.
64. Ratner AV, Muller HH, Bradley-Simpson B, Hirst D, Pitts W, Young SW. Detection of acute radiation damage to the spleen in mice by using fluorine-19 MR imaging. Am. J. Roentgenol. 1988; 151(3): 477-480.
65. 19F magnetic resonance imaging of endogenous macrophages in inflammation. WIREs Nanomed. Nanobiotechnol. 2012; 4(3): 329-343.
66. 19F-magnetic resonance imaging and perfluorocarbons. WIREs Nanomed. Nanobiotechnol. 2012; 4(4): 438-447.
67. Bonetto F, Srinivas M, Heerschap A, Mailliard R, Ahrens ET, Figdor CG, de Vries IJM. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int. J. Cancer 2011; 129(2): 365-373.
68. Hu LZ, Hockett FD, Chen JJ, Zhang L, Caruthers SD, Lanza GM, Wickline SA. A generalized strategy for designing F-19/H-1 dual-frequency MRI coil for small animal imaging at 4.7 Tesla. J. Magn. Reson. Imaging 2011; 34(1): 245-252.
69. Hockett FD, Wallace KD, Schmieder AH, Caruthers SD, Pham CTN, Wickline SA, Lanza GM. Simultaneous dual frequency H-1 and F-19 open coil imaging of arthritic rabbit knee at 3 T. IEEE Trans. Med. Imaging 2011; 30(1): 22-27.
70. Mispelter J, Lupu M, Briguet A. NMR Probeheads for Biophysical and Biomedical Experiments. Imperical College: London; 2006.
71. Hayward W. Introduction to Radio Frequency Design. Prentice-Hall: Upper Saddle River, NJ; 1982.
72. van Heeswijk RB, Pilloud Y, Flugel U, Schwitter J, Stuber M. Fluorine-19 magnetic resonance angiography of the mouse. PLoS One 2012; 7(7): e42236.
73. 19F imaging agents. Magn. Reson. Med. 2011; 66(4): 1116-1122.
74. 19F MRI to investigate tumor oxygenation. Magn. Reson. Med. 2009; 62(2): 357-364.
75. 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn. Reson. Med. 1994; 32(1): 88-97.
76. Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang JM, Kiefer B, Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002; 47(6): 1202-1210.
77. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999; 42(5): 952-962.
78. Kim YC, Narayanan SS, Nayak KS. Accelerated three-dimensional upper airway MRI using compressed sensing. Magn. Reson. Med. 2009; 61(6): 1434-1440.
79. Liang D, Liu B, Wang JJ, Ying L. Accelerating SENSE using compressed sensing. Magn. Reson. Med. 2009; 62(6): 1574-1584.
80. Schirra CO, Weiss S, Krueger S, Pedersen SF, Razavi R, Schaeffter T, Kozerke S. Toward true 3D visualization of active catheters using compressed sensing. Magn. Reson. Med. 2009; 62(2): 341-347.
81. Ajraoui S, Lee KJ, Deppe MH, Parnell SR, Parra-Robles J, Wild JM. Compressed sensing in hyperpolarized He-3 lung MRI. Magn. Reson. Med. 2010; 63(4): 1059-1069.
82. Kampf T, Fischer A, Basse-Lusebrink TC, Ladewig G, Breuer F, Stoll G, Jakob PM, Bauer WR. Application of compressed sensing to in vivo 3D F-19 CSI. J. Magn. Reson. 2010; 207(2): 262-273.
83. Yerly J, Lauzon ML, Chen HS, Frayne R. A simulation-based analysis of the potential of compressed sensing for accelerating passive mr catheter visualization in endovascular therapy. Magn. Reson. Med. 2010; 63(2): 473-483.
84. Zhong J, Mills PH, Hitchens TK, Ahrens ET. Accelerated fluorine-19 MRI cell tracking using compressed sensing. Magn. Reson. Med. 2012 (in press).
85. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn. Reson. Med. 1995; 34(6): 910-914.
86. Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J. Comput. Assist. Tomogr. 2003; 27(6): 825-846.
87. Idiyatullin D, Corum C, Park JY, Garwood M. Fast and quiet MRI using a swept radiofrequency. J. Magn. Reson. 2006; 181(2): 342-349.
88. Pipe JG. Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn. Reson. Med. 1999; 42(5): 963-969.
89. Stehning C, Bornert P, Nehrke K, Eggers H, Stuber M. Free-breathing whole-heart coronary MRA with 3D radial SSFP and self-navigated image reconstruction. Magn. Reson. Med. 2005; 54(2): 476-480.
90. 19F in a rabbit abscess model. Artif. Cells Blood Substit. Immobil. Biotechnol. 1994; 22(4): 1449-1454.
91. 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr. Med. Chem. 2005; 12(7): 819-848.
92. 19F NMR spectroscopy of perfluorocarbon. Magn. Reson. Med. 1993; 29(3): 296-302.
93. 19F MR EPI and electrodes. Adv. Exp. Med. Biol. 2003; 530: 19-27.
94. Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol. 2004; 386: 378-418.
95. Sotak CH, Hees PS, Huang HN, Hung MH, Krespan CG, Raynolds S. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn. Reson. Med. 1993; 29(2): 188-195.
96. Mason RP, Nunnally RL, Antich PP. Tissue oxygenation - a novel determination using F-19 surface coil nmr-spectroscopy of sequestered perfluorocarbon emulsion. Magn. Reson. Med. 1991; 18(1): 71-79.
97. 19F NMR relaxometry of a perfluorocarbon emulsion. Magn. Reson. Med. 1993; 29(3): 303-310.
98. Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, Hahn EW. Non-invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 1994; 29(1): 95-103.
99. 19F-MR relaxometry. Int. J. Radiat. Oncol. Biol. Phys. 1999; 44(3): 649-658.
100. Cohn SM. Oxygen therapeutics in trauma and surgery. J. Trauma 2003; 54(5): S193-S198.
101. 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest. Radiol. 2006; 41(3): 305-312.